Related Experiment Video
Updated: Aug 11, 2026
Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
Published on: January 27, 2019
Immunotypes of Chlamydia trachomatis isolated from genital tract specimens in Tahiti
E Chungue1, J Soulier, G Philippon
1Unité de Virologie, Institut Territorial de Recherches Médicales Louis Malardé, Papeete-Tahiti, French Polynesia.
Insights
This study identified the distribution of Chlamydia trachomatis immunotypes in Tahiti. Serovar E was the most prevalent, followed by F and G, with comparisons made to global Chlamydia trachomatis serovar patterns.
Area of Science:
- Microbiology
- Immunology
- Public Health
Background:
- Chlamydia trachomatis is a leading cause of sexually transmitted infections globally.
- Understanding the distribution of its immunotypes (serovars) is crucial for effective disease control and vaccine development.
Purpose of the Study:
- To determine the prevalence and distribution of Chlamydia trachomatis immunotypes in Tahiti.
- To compare the local immunotype distribution with that of other geographical regions.
Main Methods:
- Immunotyping of 115 Chlamydia trachomatis isolates from patients in Tahiti using monoclonal antibodies.
- Application of the micro-immunofluorescence test for serovar identification.
Main Results:
- Eight Chlamydia trachomatis immunotypes were identified: E (51.3%), F (16.5%), G (13%), H (5.2%), J (6.9%), D (3.5%), K (1.7%), and I (0.9%).
- Serovar E was the most dominant immunotype.
- One isolate with mixed immunotypes (EJ) was also detected.
Conclusions:
- The study provides the first detailed distribution of Chlamydia trachomatis immunotypes in Tahiti.
- The identified serovar distribution pattern may inform regional public health strategies for Chlamydia trachomatis control.
Abstract:
The distribution of Chlamydia trachomatis immunotypes (serovars) in Tahiti was studied by immunotyping of local isolates using monoclonal antibodies in the micro-immunofluorescence test. From 115 isolates obtained from the genital tracts of patients attending a sexually transmitted diseases clinic and other gynecological consultations, eight immunotypes were identified: E (51.3%), F (16.5%), G (13%), H (5.2%), J (6.9%), D (3.5%), K (1.7%) and I (0.9%). In addition, an isolate with mixed immunotypes, EJ (0.9%), was observed. This distribution was compared with those in different geographical areas.
